Paul Andrew Moore, Chief Scientific Officer at Zymeworks Inc. (ZYME), sold 42,400 shares at $14.92 ($633K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Open-market sale of $633k ZYME by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.92 | 9,792 | $146K | 23.1% |
| 2 | $14.92 | 9,792 | $146K | 23.1% |
| 3 | $14.92 | 11,408 | $170K | 26.9% |
| 4 | $14.92 | 11,408 | $170K | 26.9% |
| Total | $14.92 avg | 42,400 | $633K | 100% |
| Filing → |
| ZYME | SELL | 2024-01-08 | $106K | — | Filing → |